Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Systematic reviews (SRs) can help decision makers interpret the deluge of published biomedical literature. However, a SR may be of limited use if the methods used to conduct the SR are flawed, and reporting of the SR is incomplete. To our knowledge, since 2004 there has been no cross-sectional study of the prevalence, focus, and completeness of reporting of SRs across different specialties. Therefore, the aim of our study was to investigate the epidemiological and reporting characteristics of a more recent cross-section of SRs. METHODS AND FINDINGS: We searched MEDLINE to identify potentially eligible SRs indexed during the month of February 2014. Citations were screened using prespecified eligibility criteria. Epidemiological and reporting characteristics of a random sample of 300 SRs were extracted by one reviewer, with a 10% sample extracted in duplicate. We compared characteristics of Cochrane versus non-Cochrane reviews, and the 2014 sample of SRs versus a 2004 sample of SRs. We identified 682 SRs, suggesting that more than 8,000 SRs are being indexed in MEDLINE annually, corresponding to a 3-fold increase over the last decade. The majority of SRs addressed a therapeutic question and were conducted by authors based in China, the UK, or the US; they included a median of 15 studies involving 2,072 participants. Meta-analysis was performed in 63% of SRs, mostly using standard pairwise methods. Study risk of bias/quality assessment was performed in 70% of SRs but was rarely incorporated into the analysis (16%). Few SRs (7%) searched sources of unpublished data, and the risk of publication bias was considered in less than half of SRs. Reporting quality was highly variable; at least a third of SRs did not report use of a SR protocol, eligibility criteria relating to publication status, years of coverage of the search, a full Boolean search logic for at least one database, methods for data extraction, methods for study risk of bias assessment, a primary outcome, an abstract conclusion that incorporated study limitations, or the funding source of the SR. Cochrane SRs, which accounted for 15% of the sample, had more complete reporting than all other types of SRs. Reporting has generally improved since 2004, but remains suboptimal for many characteristics. CONCLUSIONS: An increasing number of SRs are being published, and many are poorly conducted and reported. Strategies are needed to help reduce this avoidable waste in research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many systematic review reports include narrative summaries of the characteristics and risk of bias across all included studies.36”
From PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews (2021) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even for those studies which explicitly reference PRISMA, there is only slight, statistically non-significant evidence of improved reporting, as found by Page et al. [15].”
From PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The studies included in a systematic review will generally vary with respect to design, study populations, and risk of bias [1].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in a survey of 300 systematic reviews, 64% of the reviews included observational studies [7].”
From Methods to systematically review and meta-analyse observational studies: a systematic scoping review of recommendations (2018) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although few published evaluations exist, evidence suggests that the endorsement of PRISMA by journals is associated with more complete reporting of systematic reviews than in journals not endorsing the reporting guideline.50 51 52”
From Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. (2022) · cites this paper as [51]
Experimental — accuracy not yet measured
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Self-citationPreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Self-citationPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Self-citationThe Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Self-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Self-citationPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Self-citationDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Self-citation(2014) · Medical Entomology and Zoology · Cited by 17,633
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120
Self-citationSterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“, a meta-analysis that included at least ten studies [25]).”
BackgroundSelf-citationROBIS: A new tool to assess risk of bias in systematic reviews was developed
Whiting, P., Savović, J., Higgins, J. P. T., Caldwell, D. M., Reeves, B. C., Shea, B., Davies, P., Kleijnen, J., & Churchill, R. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.06.005 · Cited by 2,272
Increasing value and reducing waste in research design, conduct, and analysis
Ioannidis, J. P. A., Greenland, S., Hlatky, M. A., Khoury, M. J., Macleod, M. R., Moher, D., Schulz, K. F., & Tibshirani, R. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62227-8 · Cited by 1,597
Self-citationReducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319 · cited 1×
“However, a SR may be of limited use to decision makers if the methods used to conduct the SR are flawed, and reporting of the SR is incomplete [4,5].”
MethodSelf-citationStatistics Notes: The odds ratio
Bland, J. M. (2000) · BMJ · doi:10.1136/bmj.320.7247.1468 · Cited by 1,294
Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?
Bastian, H., Glasziou, P., & Chalmers, I. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000326 · Cited by 1,188 · cited 1×
“, [13]) or reporting characteristics of SRs in specific fields (e.”
BackgroundEpidemiology and reporting characteristics of systematic reviews.
Moher, D., Tetzlaff, J., Tricco, A. C., Sampson, M., & Altman, D. G. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040078 · Cited by 891 · cited 8×
“for the 2004 sample (“the authors’ stated objective was to summarize evidence from multiple studies and the article described explicit methods, regardless of the details provided”) [6] ignores the evolution of SR terminology over time.”
BackgroundMethodResultInfluentialSelf-citationPRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
Beller, E. M., Glasziou, P. P., Altman, D. G., Hopewell, S., Bastian, H., Chalmers, I., Gøtzsche, P. C., Lasserson, T., Tovey, D., & for the PRISMA for Abstracts Group (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001419 · Cited by 706 · cited 2×
“Major events include the publication of the PRISMA reporting guidelines for SRs [7,8] and SR abstracts [9] and their subsequent endorsement in top journals, the launch of the Institute of Medicine’s standards for SRs of comparative effectiveness research [10], methodological developments such as a new tool to assess t…”
BackgroundMethodSelf-citationSchünemann, H. J., Wiercioch, W., Etxeandia, I., Falavigna, M., Santesso, N., Mustafa, R., Ventresca, M., Brignardello-Petersen, R., Laisaar, K.-T., Kowalski, S., et al. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131237 · Cited by 686
Increasing value and reducing waste in biomedical research: who's listening?
Moher, D., Glasziou, P., Chalmers, I., Nasser, M., Bossuyt, P. M. M., Korevaar, D. A., Graham, I. D., Ravaud, P., & Boutron, I. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00307-4 · Cited by 462 · cited 2×
“Further, collaboration between key stakeholders (funders, journals, academic institutions) is needed to address poor reporting [26].”
BackgroundSelf-citationMurad, M. H., Montori, V. M., Ioannidis, J. P. A., Jaeschke, R., Devereaux, P. J., Prasad, K., Neumann, I., Carrasco-Labra, A., Agoritsas, T., Hatala, R., et al. (2014) · JAMA · doi:10.1001/jama.2014.5559 · Cited by 454 · cited 1×
“, what are the benefits and harms of therapeutic interventions, what is the accuracy of diagnostic tests) [2,3].”
BackgroundFinding What Works in Health Care: Standards for Systematic Reviews
Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Board on Health Care Services, & Institute of Medicine (2011) · doi:10.17226/13059 · Cited by 289
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses
Hart, B., Lundh, A., & Bero, L. (2012) · BMJ · doi:10.1136/bmj.d7202 · Cited by 255
Overlapping meta-analyses on the same topic: survey of published studies
Siontis, K. C., Hernandez-Boussard, T., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f4501 · Cited by 248 · cited 1×
“This has resulted in a large number of overlapping SRs (one estimate suggests 67% of meta-analyses have at least one overlapping meta-analysis within a 3-y period) [33].”
BackgroundEstablishing a new journal for systematic review products
Moher, D., Stewart, L., & Shekelle, P. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-1 · Cited by 245 · cited 1×
“Major events include the publication of the PRISMA reporting guidelines for SRs [7,8] and SR abstracts [9] and their subsequent endorsement in top journals, the launch of the Institute of Medicine’s standards for SRs of comparative effectiveness research [10], methodological developments such as a new tool to assess t…”
MethodSelf-citationStevens, A., Shamseer, L., Weinstein, E., Yazdi, F., Turner, L., Thielman, J., Altman, D. G., Hirst, A., Hoey, J., Palepu, A., et al. (2014) · BMJ · doi:10.1136/bmj.g3804 · Cited by 242 · cited 1×
“The extent to which journals endorse PRISMA is highly variable, with some explicitly requiring authors to submit a completed checklist at the time of manuscript submission, others only recommending its use in the instructions to authors, and many not referring to it at all [38,39].”
BackgroundSelf-citationChanging Incentives to Publish
Franzoni, C., Scellato, G., & Stephan, P. (2011) · Science · doi:10.1126/science.1197286 · Cited by 230
Saini, P., Loke, Y. K., Gamble, C., Altman, D. G., Williamson, P. R., & Kirkham, J. J. (2014) · BMJ · doi:10.1136/bmj.g6501 · Cited by 209 · cited 1×
“However, reporting of both zero and non-zero harm events is necessary so that patients and clinicians can determine the risk–benefit profile of an intervention [36].”
BackgroundSelf-citationTunis, A. S., McInnes, M. D. F., Hanna, R., & Esmail, K. (2013) · Radiology · doi:10.1148/radiol.13130273 · Cited by 146 · cited 1×
“, physical therapy [14], complementary and alternative medicine [15], and radiology [16]).”
BackgroundBarnes, C., Boutron, I., Giraudeau, B., Porcher, R., Altman, D. G., & Ravaud, P. (2015) · BMC Medicine · doi:10.1186/s12916-015-0460-y · Cited by 135
Self-citationSynthesizing Evidence: Shifting the Focus From Individual Studies to the Body of Evidence
Murad, M. H., & Montori, V. M. (2013) · JAMA · doi:10.1001/jama.2013.5616 · Cited by 104 · cited 1×
“, what are the benefits and harms of therapeutic interventions, what is the accuracy of diagnostic tests) [2,3].”
BackgroundFew systematic reviews exist documenting the extent of bias: a systematic review
Tricco, A. C., Tetzlaff, J., Sampson, M., Fergusson, D. A., Cogo, E., Horsley, T., & Moher, D. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.10.017 · Cited by 93 · cited 1×
“Such bias can occur for several reasons, including use of inappropriate eligibility criteria, failure to use methods that minimize error in data collection, selective inclusion of the most favourable results from study reports, inability to access unpublished studies, and inappropriate synthesis of clinically heteroge…”
BackgroundSelf-citationFour Proposals to Help Improve the Medical Research Literature
Moher, D., & Altman, D. G. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001864 · Cited by 78 · cited 1×
“Also, journal editors could receive certified training in how to endorse and implement PRISMA and facilitate its use by peer reviewers [42].”
BackgroundSelf-citationThe Geometric Increase in Meta-Analyses from China in the Genomic Era
Ioannidis, J. P. A., Chang, C. Q., Lam, T. K., Schully, S. D., & Khoury, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065602 · Cited by 62 · cited 1×
“Further, some countries, particularly China, have developed a research culture that places a strong emphasis on the production of SRs [27].”
BackgroundJones, C. W., Keil, L. G., Weaver, M. A., & Platts-Mills, T. F. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-126 · Cited by 61 · cited 1×
“, trial registries, regulatory databases), despite their ability to reduce the impact of reporting biases [34,35].”
BackgroundSmith, T. A., Kulatilake, P., Brown, L. J., Wigley, J., Hameed, W., & Shantikumar, S. (2015) · Annals of Medicine & Surgery · doi:10.1016/j.amsu.2014.12.003 · Cited by 52 · cited 1×
“The extent to which journals endorse PRISMA is highly variable, with some explicitly requiring authors to submit a completed checklist at the time of manuscript submission, others only recommending its use in the instructions to authors, and many not referring to it at all [38,39].”
BackgroundSurvey of the Reporting Characteristics of Systematic Reviews in Rehabilitation
Gianola, S., Gasparini, M., Agostini, M., Castellini, G., Corbetta, D., Gozzer, P., Li, L. C., Sirtori, V., Taricco, M., Tetzlaff, J. M., et al. (2013) · Physical Therapy · doi:10.2522/ptj.20120382 · Cited by 34 · cited 2×
“, physical therapy [14], complementary and alternative medicine [15], and radiology [16]).”
BackgroundResultSelf-citationTurner, L., Galipeau, J., Garritty, C., Manheimer, E., Wieland, L. S., Yazdi, F., & Moher, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053536 · Cited by 27 · cited 3×
“, physical therapy [14], complementary and alternative medicine [15], and radiology [16]).”
BackgroundMethodResultSelf-citationFrom Checklists to Tools: Lowering the Barrier to Better Research Reporting
Editors, T. P. M. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001910 · Cited by 25 · cited 1×
“One strategy is to develop software that facilitates the completeness of SR reporting [41].”
Background
Research works printed but not linked: 2
- Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No. 10(14)-EHC063-EF. 2014 Jan [cited 21 Apr 2016]. Available: https://www.effectivehealthcare.ahrq.gov/ehc/products/60/318/CER-Methods-Guide-140109.pdf. 21433403
- Nordic Cochrane Centre. Review Manager (RevMan), version 5.1. Copenhagen: Nordic Cochrane Centre; 2011.
Cited by
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Self-citationThe PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Self-citationPage, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Self-citationThe PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Self-citationShea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636
Self-citation
Metadata
- Authors
- Page, M. J., Shamseer, L., Altman, D. G., Tetzlaff, J., Sampson, M., Tricco, A. C., Catalá-López, F., Li, L., Reid, E. K., Sarkis-Onofre, R., & Moher, D.
- Affiliations
- University of Bristol (GB)
- University of Ottawa (CA)
- University of Oxford (GB)
- Ottawa Hospital Research Institute (CA)
- Children's Hospital of Eastern Ontario (CA)
- St. Michael's Hospital (CA)
- Universitat de València (ES)
- Lanzhou University (CN)
- Vancouver General Hospital (CA)
- Corresponding author
- Moher, David
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-05-24
- Volume
- 13
- Issue
- 5
- Pages
- e1002028
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC4878797
- OpenAlex
- W2396846174
- Semantic Scholar
- 363d54e2baf229adfd585079bfd7c18ae8feed26
- Cited by
- 768
- References
- 41
- Citations by year
- 2026: 25 · 2025: 43 · 2024: 85 · 2023: 73 · 2022: 85 · 2021: 146 · 2020: 95 · 2019: 83 · 2018: 58 · 2017: 60 · 2016: 15
- FWCI
- 24.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion, other-oa)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- Lanzhou University Institutional Repository (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, other-oa)
- Funders
- National Institute for Health and Care Research
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Governo Brasil
- Generalitat Valenciana (PROMETEOII/2015/021)
- Canadian Institutes of Health Research (1088535)
- Medical Research Council (MR/J00488X/1)
- National Health and Medical Research Council (1088535)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › scientometrics and bibliometrics research
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Keywords
- systematic reviews, reporting quality, meta-analysis, risk of bias assessment, publication bias, research funding disclosure, biomedical literature, research quality improvement, research integrity, research transparency, research accountability, research reproducibility, research credibility, research trustworthiness
- MeSH terms
- Cross-Sectional Studies, Epidemiologic Methods, Humans, Research Design, Review Literature as Topic, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.